The economic aspects of hepatitis C-- implications for haemophilia.
This paper considers the literature relating to the course of hepatitis C infection and its implications for those with haemophilia. It goes on to discuss a model that assessed the economic aspects of treating hepatitis C cases with interferon-alpha, discusses recent changes in recommended treatment of hepatitis C and critically reviews the model and its application to patients with haemophilia.